TREATMENT TO RESTORE VISION AND
READ WITHOUT
GLASSES NOR SURGERY
HOW TO STOP PRESBYOPIA AND RECOVER
VISION
For over some decades
ophthalmologists have been treating presbyopia with drugs with the aim of
stopping it and helping patients to recover their vision.
The simplest non invasive treatment
consists of using drops which give the eye back its aptitude to focus, the same
way we could do when we were young without the need of glasses.
This medicine is obtained from a
medicinal plant which was used by the aborigines of the north of Brazil before
colonization.
The great majority of the patients
who begin this treatment manage to drive, work, read, use the computer and
write text messages without the need of glasses.
Due to the rising requirements of
our society in general and of technological advances in particular, we have
observed an increase in the demand of solutions to improve and preserve vision
over the last years.
Our recommendation is to use
preventive treatments which are neither invasive nor risky and to pay attention
to some simple habits such as: being moderate with muscle relaxants and
psychoactive drugs (sedatives and tranquilizers), wearing glasses for
presbyopia as little as possible, reading using good quality light (if possible
solar or incandescent) and avoiding wearing glasses while walking, including
either bifocals or multifocals.
Preventive treatment
Successful research has been
carried out for over the past decades on presbyopia and hyperopia treatment and
some diseases of the accommodation and refraction of the eye.
As a result, significant progress
has been made in the knowledge and treatment of diseases of the visual system
(related to genetic influence as in the case of hyperopia or caused by aging as
presbyopia) allowing to reduce or to stop the advancement of the loss of vision
in a great number of people.
The preventive treatment is drug
based. It has been used in research for over thirty years and at present is
administered combining drugs.
It is a very simple method and it
is the most appropriate one for those willing to stop wearing glasses.
The composition and dosage varies
according to each particular case and is administered following medical
evaluation.
In short, the idea is to find the
solution for presbyopia and to preserve a good quality of vision during our
entire life, which is both the wish of our patients and what is expected from
us.
Special offer of drops for presbyopia
People who would like to try the effect of this treatment will receive a bottle with the drops in the adequate doses without charge.
This way we offer the possibility to prove the quality of this treatment.
IN WHICH CASES SHOULDN’T THE TEST BE DONE?
Traumatism of the eye
Anterior or posterior uveitis
Vitreous detachment
Myopia higher than -1
Cataract
Migraine
Special offer of drops for presbyopia
TEST DROPS FOR PRESBYOPIA AND HYPEROPIA
People who would like to try the effect of this treatment will receive a bottle with the drops in the adequate doses without charge.
In order to test the drops at your home, ask for instructions:
Email: argonzalezsantos@gmail.com
International dialing 549 11 60 23 64 07
DROPS TO SEE BETTER
Special treatment for presbyopia and hyperopia
You can prove that it is possible to read again without glasses. It can be done at your home or at our office in Buenos Aires
Tel. (011) 15 60 23 64 07
argonzalezsantos@gmail.com
BUENOS AIRES
LIBERTAD 1173 PISO 2 ´´ A´´ C.A.B.A. TEL. 48126239
http://www.consultoriosprofesionales.com/ficha.php?id=472Tel. (011) 15 60 23 64 07
argonzalezsantos@gmail.com
BUENOS AIRES
REPÚBLICA ARGENTINA
This way we offer the possibility to prove the quality of this treatment.
DURATION OF THE TEST AT OUR OFFICES
The test is between one and two hours long.
The test is between one and two hours long.
You can either ask for an appointment for this test without charge in any of our offices or have the drops delivered to your home and ask for instructions.
IN WHICH CASES SHOULDN’T THE TEST BE DONE?
When there is:
Detachment of the retina
Maculopathy
Detachment of the retina
Maculopathy
Haemorrhage
Diabetic retinopathy Traumatism of the eye
Anterior or posterior uveitis
Vitreous detachment
Myopia higher than -1
Cataract
Migraine
WHAT IS FARSIGHTEDNESS?
Hyperopia, also known as farsightedness, longsightedness or
hypermetropia, is a defect of vision caused by an imperfection in the eye
refraction which affects about 10 percent of population.
Hyperopia develops in eyes that focus images behind the retina
instead of on the retina, which can result in blurred vision.
This occurs when the eyeball is too short, which prevents incoming
light from focusing directly on the retina. It may also be caused by an
abnormal shape of the cornea or lens.
Farsightedness often starts in early childhood. But normal growth
corrects the problem. If a child is still a bit farsighted when the eye has
stopped growing (at around 9 years of age), the eye can usually adjust to make
up for the problem. This allows the child to see clearly. But as we age, our
eyes can no longer adjust as well, and farsightedness becomes more obvious.
Symptoms and clasification
Young people with mild to moderate hyperopia are often able to see
clearly because their natural lens can adjust, or accommodate to increase the
eye’s focusing ability. However, as the eye gradually loses the ability to
accommodate (beginning at about 40 years of age), blurred vision from hyperopia
often becomes more apparent.
Symptoms depend on the degree of hyperopia. Some individuals may
have no symptoms, while others have blurry near vision and clear distance vision,
and those with the most severe cases have blurry near and distance vision.
Headaches and eyestrain may also occur, particularly when doing close work.
People with hyperopia can experience blurred vision, asthenopia,
accommodative dysfunction, binocular dysfunction, amblyopia, and strabismus.
Hyperopia is typically classified according to clinical
appearance, its severity, or how it relates to the eye's accommodative status.
Various eye care professionals, including ophthalmologists,
optometrists, orthoptists, and opticians, are involved in the treatment and
management of hyperopia.
There is already a variety of existing methods, some drug based,
others optical and surgical. All of them are used efficiently meeting the
requirements of the different stages of the eye disorder, both prematurely
working with prevention and later with recovery of the vision.
Minor amounts of hyperopia are sometimes left uncorrected.
However, larger amounts may be corrected with convex lenses in eyeglasses or
contact lenses. Convex lenses have a positive dioptric value, which causes the
light to focus closer than its normal range.
Hyperopia is sometimes correctable with various refractive surgery
procedures;LASIK or conductive keratoplasty. It can also be corrected with implanted
special concave lenses.
Moreover, the benefits of this treatment are to avoid both the
dependence on glasses and the rebound effect of glasses, to improve close and
far vision and to recover or avoid blurred vision caused by some medicaments
such as muscle relaxants and psychoactive drugs (sedatives and tranquilizers).
Thus, this treatment provides the great majority of its users the
satisfaction of maintaining their vision in spite of years going by. And a
great number of people who could only see properly wearing glasses or contact
lenses can improve their vision significantly.
As regards present treatments which are optical or surgical, the
administration of this medicament is helpful since it avoids progressive
changes in the adjustment of glasses and prevents relapse of hyperopia in the
post operation period.
As a preventive method, its efficacy varies according to the
patient’s age when starting the treatment.
Its strongest effect is between thirty five and sixty nine years
old.
It can be administered among children and youngsters as well.
The duration of the treatment is optional and it depends on each
individual; it can even be continued for a lifetime.
Stopping the treatment does not have unwanted effects and it is
observed that the vision returns to the level at the starting point, according
to the patient’s age and previous refraction.
In very few cases has the treatment been cancelled due to adverse
effects such as allergic reactions in the conjunctiva or cephalea in
hyperreactive patients.
Scientific base principles.
The ciliary muscle controls the shape of the lens through
suspended suspensory ligaments called zonules. This provides the acomodation
ability to the eye.
Like most smooth muscles, the ciliary muscle has a dual innervation,
receiving both sympathetic and parasympathetic fibers.
In the ciliary muscle, the contraction necessary for accommodation
is under parasympathetic control.
Most current theories of accommodation assume that the condition
of physiological rest of accommodation occurs when the emmetropic eye focuses
on a distant target, demanding good resolution.
Accordingly, in the natural resting state of the eye, the
parasympathetic system maintains ciliary muscle tone, i.e., the ciliary muscle
is contracted and zonular tension is relaxed such that the lens is more
spherical and in a forward position increasing the refractive power of the eye.
Thus, the eye is naturally in a “tonic accommodative” state and with
appropriate stimulus is capable of further active positive accommodation.
Aging studies on the brain have demonstrated a loss of function of
the parasympathetic system that is due to a decline in the neurotransmitter
substance acetylcholine. This is probably due to a decreased production by the
enzyme cholineacetyl transferate (CHAT) acetylcholine synthetase as there is no
decline in parasympathetic receptor cells with age. That is, the ciliary muscle
has the same number of receptors and the contractile ability of the muscle is
the same in young and old individuals.
The administration of the lacking neurotransmitter or muscarinic
agonist may restore the lost vision
This compounds are known in the art for their purposes, and are
known to be safe under ordinary conditions of use.
(Traitement
médical des vices de réfraction, in J. Sédan e altri, Thérapeutique
médicale oculaire, Paris 1957, pp. 1228-1237).
HUGONNIER, R. – CLAYETTE-HUGONNIER, S. —
STRABISMES, HETEROPHORIES, PARALISIS OCULOMOTRICES (les dese- quilibres
oculo-moteurs en clinique). Paris, Masson, 1959 (554- 556) TRAITEMENT MÉDICAL
GÉNÉRAL ET LOCAL
Thus, the treatment can be administered by substantially
conventional means, consistent with known eye treatments, and while avoiding
irritation, discomfort or the need of unusual application procedures.
Variaciones de la Agudeza Visual luego de
Administrar Pilocarpina y Tetrahidrozolina a
Pacientes Hipermétropes
Dr. Alejandro González Santos
ARCH. OFTAL. B. AIRES; vol 81 nº 2; pág 51-55; 2010
http://sao.org.ar/LinkClick.aspx?fileticket=6Ld8dL-HbfA%3D&tabid=492&language=es-AR
Cabe mencionar al Dr. Jorge Benozzi, quien en los últimos años patentó un método que lleva su nombre, obteniendo el premio INNOVAR y otras menciones que han hecho un gran aporte a la difusión de este tratamiento, con los que ha contribuido a popularizar el conocimiento de este tratamiento en todo el continente americano y algunos países de Europa. (METODO BENOZZI)
Variaciones de la Agudeza Visual luego de
Administrar Pilocarpina y Tetrahidrozolina a
Pacientes Hipermétropes
Dr. Alejandro González Santos
ARCH. OFTAL. B. AIRES; vol 81 nº 2; pág 51-55; 2010
Purpose: To determine up to which extent visual acuity (VA) can be increased in hyperopic patients after extended administration of an association of cholinergic and alfa adrenergic drug.
Results: Visual acuity with no optical correction increased between 1 and 9 lines in the decimal scale at a distance of 6 meters compared to previous levels of VA of the patients before starting the treatment.
CONTACT
Dr. Alejandro González Santos.
Medical Doctor specializing in Ophthalmology
Director of CENTRO PARA LA VISION.
Former Department Chairman at OPHTALMOLOGICAL HOSPITAL Dr. P. LAGLEYZE
LIBERTAD 1173 PISO 2 ´´ A´´ C.A.B.A. TEL. 48126239
http://www.consultoriosprofesionales.com/ficha.php?id=472
BUENOS AIRES.
REPÚBLICA ARGENTINA
Te. 5491160236407
National Matriculation Number 47737